-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Amylyx Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2021 to Q2 2024.
- Amylyx Pharmaceuticals, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $75.3M, a 3.53% decline year-over-year.
- Amylyx Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $477M, a 74.6% increase year-over-year.
- Amylyx Pharmaceuticals, Inc. annual Costs and Expenses for 2023 was $342M, a 53% increase from 2022.
- Amylyx Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $224M, a 169% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)